EBUS-TBNA for Diagnosis of Mediastinal Lymphadenopathy

• Conditions: Mediastinal Lymphadenopathy; Lung Cancer

• Registration Number: NCT01493739
• Lead Sponsor: Chang Gung Memorial Hospital

Brief Summary

This study aims on the combinatorial results of cytology, histopathology and microbiology obatined by EBUS-TBNA for unselected mediastina lesions.

Detailed Description

A number of studies have proved EBUS-TBNA to be useful for lymph node staging in lung cancer. The diagnostic performance is equivalent to mediastinoscopy while the invasiveness is far less. This study primarily focusing on merged approach of cytology, histopathology and microbioloogy obatined by EBUS-TBNA for unselected mediastina lesions.

Study Timeline

• Study Start: 2009-01
• Study First Submitted: 2011-11-21
• Status Verified: 2011-12
• Study First Submitted QC: 2011-12-15
• Last Update Submitted: 2011-12-15
• Study First Posted: 2011-12-16
• Last Update Posted: 2011-12-16
• Primary Completion: 2012-01
• Study Completion: 2012-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Age > 18 years old
• mediastinal lymphadenopathy on Chest CT scan
• with a short-axis > 10mm

Exclusion Criteria

• patients intolerant to bronchoscopy exam
• unstable vital sign (Blood pressure, heart rate, breath rate)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnostic rate	Participant will be followed within an average of three months

Trial Locations

Locations (1)

Chang Gung Memorial Hospital; 🇨🇳 Taipei, Taiwan